# US 2021/0343950 A1 · Organic electroluminescent materials and devices

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0343950 A1
- Document ID: US20210343950A1
- Status: Published application
- Kind: A1
- Application number: 17/338,793
- Filed: 2021-06-04
- Published: 2021-11-04
- Earliest claimed: 2016-11-11
- Assignees: Universal Display Corporation
- Applicants: Universal Display Corporation
- Inventors: Zhiqiang Ji; Lichang Zeng
- Web page: https://patentgrep.com/patent/US20210343950A1

## CPC

- H10K 85/342: {comprising iridium}
- C07D 495/04: Ortho-condensed systems
- C07F 15/0033: {Iridium compounds}
- C09K 11/02: Use of particular materials as binders, particle coatings or suspension media therefor
- C09K 11/06: containing organic luminescent materials
- H10K 85/657: {Polycyclic condensed heteroaromatic hydrocarbons}
- C09K 2211/1037: with sulfur
- C09K 2211/185: of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
- H10K 50/11: characterised by the electroluminescent [EL] layers
- H10K 2101/10: Triplet emission
- H10K: ORGANIC ELECTRIC SOLID-STATE DEVICES
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE

## Abstract

The present invention includes novel six member aromatic or heteroaromatic rings fused to aza-DBX as ligands for making dopants for OLED applications.

## Claims

### Claim 1

A compound comprising a ligand LA of Formula (I):
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
wherein R1 represents from none to the maximum possible number of substitution;
wherein R2 represents from two to the maximum possible number of substitution;
wherein at least two adjacent R2s are joined to form ring C and have the following formula, wherein ring C is fused to ring B:
wherein the wave lines indicate bonds to ring B;
wherein ring D and ring E are each independently a 6-membered aromatic ring;
wherein ring D fuses to ring C, and ring E fuses to ring D;
wherein ring D and ring E can be further substituted by one or more substituents;
wherein X is selected from the group consisting of O, S, Se, and NR;
wherein R1, R2, and R are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;
wherein LA is coordinated to a metal M;
wherein LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein M is optionally coordinated to other ligands.

### Claim 2 (depends on 1)

The compound of claim 1, wherein M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu.

### Claim 3 (depends on 1)

The compound of claim 1, wherein M is Ir or Pt.

### Claim 4 (depends on 1)

The compound of claim 1, wherein X is O or S.

### Claim 5 (depends on 1)

The compound of claim 1, wherein X is NR.

### Claim 6 (depends on 1)

The compound of claim 1, wherein ring D and ring E are benzene.

### Claim 7 (depends on 1)

The compound of claim 1, wherein one of ring D and ring E is benzene, and the other one is pyridine.

### Claim 8 (depends on 1)

The compound of claim 1, wherein ring A is benzene.

### Claim 9 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of:
wherein Y is selected from the group consisting of O, S, Se, and NRD;
wherein RA, RB, RC, and RD each independently represents from none to the e maximum possible number of substitution;
wherein RA, RB, RC, and RD are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring; and
wherein Z1 to Z10 is each independently selected from CH and N.

### Claim 10 (depends on 1)

The compound of claim 1, wherein the ligand LA is selected from the group consisting of:

### Claim 11 (depends on 1)

The compound of claim 1, wherein the compound has formula (LA)nIr(LB)3-n;
wherein LB is a bidentate ligand; and n is 1, 2, or 3.

### Claim 12 (depends on 11)

The compound of claim 11, wherein LB is selected from the group consisting of:
LBJ, j
RB1
RB2
RB3
RB4
RB5
1.
H
H
H
H
H
2.
CH3
H
H
H
H
3.
H
CH3
H
H
H
4.
H
H
CH3
H
H
5.
H
H
H
CH3
H
6.
CH3
H
CH3
H
H
7.
CH3
H
H
CH3
H
8.
H
CH3
CH3
H
H
9.
H
CH3
H
CH3
H
10.
H
H
CH3
CH3
H
11.
CH3
CH3
CH3
H
H
12.
CH3
CH3
H
CH3
H
13.
CH3
H
CH3
CH3
H
14.
H
CH3
CH3
CH3
H
15.
CH3
CH3
CH3
CH3
H
16.
H
H
H
H
17.
CH3
H
H
H
18.
H
CH3
H
H
19.
H
H
CH3
H
20.
CH3
CH3
H
H
21.
CH3
H
CH3
H
22.
H
CH3
CH3
H
23.
CH3
CH3
CH3
H
24.
H
H
H
H
25.
CH3
H
H
H
26.
H
CH3
H
H
27.
H
H
CH3
H
28.
CH3
CH3
H
H
29.
CH3
H
CH3
H
30.
H
CH3
CH3
H
31.
CH3
CH3
CH3
H
32.
H
H
H
H
33.
CH3
H
H
H
34.
H
CH3
H
H
35.
H
H
CH3
H
36.
CH3
CH3
H
H
37.
CH3
H
CH3
H
38.
H
CH3
CH3
H
39.
CH3
CH3
CH3
H
40.
H
H
H
H
41.
CH3
H
H
H
42.
H
CH3
H
H
43.
H
H
CH3
H
44 .
CH3
CH3
H
H
45.
CH3
H
CH3
H
46.
H
CH3
CH3
H
47.
CH3
CH3
CH3
H
48.
H
H
H
H
49.
CH3
H
H
H
50.
H
CH3
H
H
51.
H
H
CH3
H
52.
CH3
CH3
H
H
53.
CH3
H
CH3
H
54.
H
CH3
CH3
H
55.
CH3
CH3
CH3
H
56.
H
H
H
H
57.
CH3
H
H
H
58.
H
CH3
H
H
59.
H
H
CH3
H
60.
CH3
CH3
H
H
61.
CH3
H
CH3
H
62.
H
CH3
CH3
H
63.
CH3
CH3
CH3
H
64.
H
H
H
H
65.
CH3
H
H
H
66.
H
CH3
H
H
67.
H
H
CH3
H
68.
CH3
CH3
H
H
69.
CH3
H
CH3
H
70.
H
CH3
CH3
H
71.
CH3
CH3
CH3
H
72.
H
H
H
H
73.
CH3
H
H
H
74.
H
CH3
H
H
75.
H
H
CH3
H
76.
CH3
CH3
H
H
77.
CH3
H
CH3
H
78.
H
CH3
CH3
H
79.
CH3
CH3
CH3
H
80.
H
H
H
H
81.
CH3
H
H
H
82.
H
CH3
H
H
83.
H
H
CH3
H
84.
CH3
CH3
H
H
85.
CH3
H
CH3
H
86.
H
CH3
CH3
H
87.
CH3
CH3
CH3
H
88.
H
H
H
H
89.
CH3
H
H
H
90.
H
CH3
H
H
91.
H
H
CH3
H
92.
CH3
CH3
H
H
93.
CH3
H
CH3
H
94.
H
CH3
CH3
H
95.
CH3
CH3
CH3
H
96.
H
H
H
H
97.
CH3
H
H
H
98.
H
CH3
H
H
99.
H
H
CH3
H
100.
CH3
CH3
H
H
101.
CH3
H
CH3
H
102.
H
CH3
CH3
H
103.
CH3
CH3
CH3
H
104.
H
H
H
H
105.
CH3
H
H
H
106.
H
CH3
H
H
107.
H
H
CH3
H
108.
CH3
CH3
H
H
109.
CH3
H
CH3
H
110.
H
CH3
CH3
H
111.
CH3
CH3
CH3
H
112.
H
H
H
H
113.
CH3
H
H
H
114.
H
CH3
H
H
115.
H
H
CH3
H
116.
CH3
CH3
H
H
117.
CH3
H
CH3
H
118.
H
CH3
CH3
H
119.
CH3
CH3
CH3
H
120.
H
H
H
H
121.
CH3
H
H
H
122.
H
CH3
H
H
123.
H
H
CH3
H
124.
CH3
CH3
H
H
125.
CH3
H
CH3
H
126.
H
CH3
CH3
H
127.
CH3
CH3
CH3
H
128.
H
H
H
H
129.
CH3
H
H
H
130.
H
CH3
H
H
131.
H
H
CH3
H
132.
CH3
CH3
H
H
133.
CH3
H
CH3
H
134.
H
CH3
CH3
H
135.
CH3
CH3
CH3
H
136.
H
H
H
H
137.
CH3
H
H
H
138.
H
CH3
H
H
139.
H
H
CH3
H
140.
CH3
CH3
H
H
141.
CH3
H
CH3
H
142.
H
CH3
CH3
H
143.
CH3
CH3
CH3
H
144.
H
H
H
H
145.
CH3
H
H
H
146.
H
CH3
H
H
147.
H
H
CH3
H
148.
CH3
CH3
H
H
149.
CH3
H
CH3
H
150.
H
CH3
CH3
H
151.
CH3
CH3
CH3
H
152.
H
H
H
H
153.
CH3
H
H
H
154.
H
CH3
H
H
155.
H
H
CH3
H
156.
CH3
CH3
H
H
157.
CH3
H
CH3
H
158.
H
CH3
CH3
H
159.
CH3
CH3
CH3
H
160.
H
H
H
161.
H
H
H
162.
H
H
H
163.
H
H
H
164.
H
H
H
165.
H
H
H
166.
H
H
H
167.
H
H
H
168.
H
H
H
169.
H
H
H
170.
H
H
H
171.
H
H
H
172.
H
H
H
173.
H
H
H
174.
H
H
H
175.
H
H
H
176.
H
H
H
177.
H
H
H
178.
CD3
H
H
H
H
179.
H
CD3
H
H
H
180.
H
H
CD3
H
H
181.
H
H
H
CD3
H
182.
CD3
H
CD3
H
H
183.
CD3
H
H
CD3
H
184.
H
CD3
CD3
H
H
185.
H
CD3
H
CD3
H
186.
H
H
CD3
CD3
H
187.
CD3
CD3
CD3
H
H
188.
CD3
CD3
H
CD3
H
189.
CD3
H
CD3
CD3
H
190.
H
CD3
CD3
CD3
H
191.
CD3
CD3
CD3
CD3
H
192.
H
H
H
H
CD3
193.
CH3
H
H
H
CD3
194.
H
CH3
H
H
CD3
195.
H
H
CH3
H
CD3
196.
H
H
H
CH3
CD3
197.
CH3
H
CH3
H
CD3
198.
CH3
H
H
CH3
CD3
199.
H
CH3
CH3
H
CD3
200.
H
CH3
H
CH3
CD3
201.
H
H
CH3
CH3
CD3
202.
CH3
CH3
CH3
H
CD3
203.
CH3
CH3
H
CH3
CD3
204.
CH3
H
CH3
CH3
CD3
205.
H
CH3
CH3
CH3
CD3
206.
CH3
CH3
CH3
CH3
CD3
207.
H
H
H
CD3
208.
CH3
H
H
CD3
209.
H
CH3
H
CD3
210.
H
H
CH3
CD3
211.
CH3
CH3
H
CD3
212.
CH3
H
CH3
CD3
213.
H
CH3
CH3
CD3
214.
CH3
CH3
CH3
CD3
215.
H
H
H
CD3
216.
CH3
H
H
CD3
217.
H
CH3
H
CD3
218.
H
H
CH3
CD3
219.
CH3
CH3
H
CD3
220.
CH3
H
CH3
CD3
221.
H
CH3
CH3
CD3
222.
CH3
CH3
CH3
CD3
223.
H
H
H
CD3
224.
CH3
H
H
CD3
225.
H
CH3
H
CD3
226.
H
H
CH3
CD3
227.
CH3
CH3
H
CD3
228.
CH3
H
CH3
CD3
229.
H
CH3
CH3
CD3
230.
CH3
CH3
CH3
CD3
231.
H
H
H
CD3
232.
CH3
H
H
CD3
233.
H
CH3
H
CD3
234.
H
H
CH3
CD3
235.
CH3
CH3
H
CD3
236.
CH3
H
CH3
CD3
237.
H
CH3
CH3
CD3
238.
CH3
CH3
CH3
CD3
239.
H
H
H
CD3
240.
CH3
H
H
CD3
241.
H
CH3
H
CD3
242.
H
H
CH3
CD3
243.
CH3
CH3
H
CD3
244.
CH3
H
CH3
CD3
245.
H
CH3
CH3
CD3
246.
CH3
CH3
CH3
CD3
247.
H
H
H
CD3
248.
CH3
H
H
CD3
249.
H
CH3
H
CD3
250.
H
H
CH3
CD3
251.
CH3
CH3
H
CD3
252.
CH3
H
CH3
CD3
253.
H
CH3
CH3
CD3
254.
CH3
CH3
CH3
CD3
255.
H
H
H
CD3
256.
CH3
H
H
CD3
257.
H
CH3
H
CD3
258.
H
H
CH3
CD3
259.
CH
CH3
H
CD3
260.
CH3
H
CH3
CD3
261.
H
CH3
CH3
CD3
262.
CH3
CH3
CH3
CD3
263.
H
H
H
CD3
264.
CH3
H
H
CD3
265.
H
CH3
H
CD3
266.
H
H
CH3
CD3
267.
CH3
CH3
H
CD3
268.
CH3
H
CH3
CD3
269.
H
CH3
CH3
CD3
270.
CH3
CH3
CH3
CD3
271.
H
H
H
CD3
272.
CH3
H
H
CD3
273.
H
CH3
H
CD3
274.
H
H
CH3
CD3
275.
CD3
CD3
CD3
CD3
CD3

### Claim 13 (depends on 10)

The compound of claim 10, wherein the compound is selected from the group consisting of Compound 1 through Compound 75650 where each Compound x has the formula Ir(LAk)(LBj)2;
wherein x=275j+k−275, k is an integer from 1 to 300, and j is an integer from 1 to 275; and
LB is selected from the group consisting of:
LBj, j
RB1
RB2
RB3
RB4
RB5
1.
H
H
H
H
H
2.
CH3
H
H
H
H
3.
H
CH3
H
H
H
4.
H
H
CH3
H
H
5.
H
H
H
CH3
H
6.
CH3
H
CH3
H
H
7.
CH3
H
H
CH3
H
8.
H
CH3
CH3
H
H
9.
H
CH3
H
CH3
H
10.
H
H
CH3
CH3
H
11.
CH3
CH3
CH3
H
H
12.
CH3
CH3
H
CH3
H
13.
CH3
H
CH3
CH3
H
14.
H
CH3
CH3
CH3
H
15.
CH3
CH3
CH3
CH3
H
16.
H
H
H
H
17.
CH3
H
H
H
18.
H
CH3
H
H
19.
H
H
CH3
H
20.
CH3
CH3
H
H
21.
CH3
H
CH3
H
22.
H
CH3
CH3
H
23.
CH3
CH3
CH3
H
24.
H
H
H
H
25.
CH3
H
H
H
26.
H
CH3
H
H
27.
H
H
CH3
H
28.
CH3
CH3
H
H
29.
CH3
H
CH3
H
30.
H
CH3
CH3
H
31.
CH3
CH3
CH3
H
32.
H
H
H
H
33.
CH3
H
H
H
34.
H
CH3
H
H
35.
H
H
CH3
H
36.
CH3
CH3
H
H
37.
CH3
H
CH3
H
38.
H
CH3
CH3
H
39.
CH3
CH3
CH3
H
40.
H
H
H
H
41.
CH3
H
H
H
42.
H
CH3
H
H
43 .
H
H
CH3
H
44.
CH3
CH3
H
H
45.
CH3
H
CH3
H
46.
H
CH3
CH3
H
47.
CH3
CH3
CH3
H
48.
H
H
H
H
49.
CH3
H
H
H
50.
H
CH3
H
H
51.
H
H
CH3
H
52.
CH3
CH3
H
H
53.
CH3
H
CH3
H
54.
H
CH3
CH3
H
55.
CH3
CH3
CH3
H
56.
H
H
H
H
57.
CH3
H
H
H
58.
H
CH3
H
H
59.
H
H
CH3
H
60.
CH3
CH3
H
H
61.
CH3
H
CH3
H
62.
H
CH3
CH3
H
63.
CH3
CH3
CH3
H
64.
H
H
H
H
65.
CH3
H
H
H
66.
H
CH3
H
H
67.
H
H
CH3
H
68.
CH3
CH3
H
H
69.
CH3
H
CH3
H
70.
H
CH3
CH3
H
71.
CH3
CH3
CH3
H
72.
H
H
H
H
73.
CH3
H
H
H
74.
H
CH3
H
H
75.
H
H
CH3
H
76.
CH3
CH3
H
H
77.
CH3
H
CH3
H
78.
H
CH3
CH3
H
79.
CH3
CH3
CH3
H
80.
H
H
H
H
81.
CH3
H
H
H
82.
H
CH3
H
H
83.
H
H
CH3
H
84.
CH3
CH3
H
H
85.
CH3
H
CH3
H
86.
H
CH3
CH3
H
87.
CH3
CH3
CH3
H
88.
H
H
H
H
89.
CH3
H
H
H
90.
H
CH3
H
H
91.
H
H
CH3
H
92.
CH3
CH3
H
H
93.
CH3
H
CH3
H
94.
H
CH3
CH3
H
95.
CH3
CH3
CH3
H
96.
H
H
H
H
97.
CH3
H
H
H
98.
H
CH3
H
H
99.
H
H
CH3
H
100.
CH3
CH3
H
H
101.
CH3
H
CH3
H
102.
H
CH3
CH3
H
103.
CH3
CH3
CH3
H
104.
H
H
H
H
105.
CH3
H
H
H
106.
H
CH3
H
H
107.
H
H
CH3
H
108.
CH3
CH3
H
H
109.
CH3
H
CH3
H
110.
H
CH3
CH3
H
111.
CH3
CH3
CH3
H
112.
H
H
H
H
113.
CH3
H
H
H
114.
H
CH3
H
H
115.
H
H
CH3
H
116.
CH3
CH3
H
H
117.
CH3
H
CH3
H
118.
H
CH3
CH3
H
119.
CH3
CH3
CH3
H
120.
H
H
H
H
121.
CH3
H
H
H
122.
H
CH3
H
H
123.
H
H
CH3
H
124.
CH3
CH3
H
H
125.
CH3
H
CH3
H
126.
H
CH3
CH3
H
127.
CH3
CH3
CH3
H
128.
H
H
H
H
129.
CH3
H
H
H
130.
H
CH3
H
H
131.
H
H
CH3
H
132.
CH3
CH3
H
H
133.
CH3
H
CH3
H
134.
H
CH3
CH3
H
135.
CH3
CH3
CH3
H
136.
H
H
H
H
137.
CH3
H
H
H
138.
H
CH3
H
H
139.
H
H
CH3
H
140.
CH3
CH3
H
H
141.
CH3
H
CH3
H
142.
H
CH3
CH3
H
143.
CH3
CH3
CH3
H
144.
H
H
H
H
145.
CH3
H
H
H
146.
H
CH3
H
H
147.
H
H
CH3
H
148.
CH3
CH3
H
H
149.
CH3
CH3
H
H
150.
H
CH3
CH3
H
151.
CH3
CH3
CH3
H
152.
H
H
H
H
153.
CH3
H
H
H
154.
H
CH3
H
H
155.
H
H
CH3
H
156.
CH3
CH3
H
H
157.
CH3
H
CH3
H
158.
H
CH3
CH3
H
159.
CH3
CH3
CH3
H
160.
H
H
H
161.
H
H
H
162.
H
H
H
163.
H
H
H
164.
H
H
H
165.
H
H
H
166.
H
H
H
167.
H
H
H
168.
H
H
H
169.
H
H
H
170.
H
H
H
171.
H
H
H
172.
H
H
H
173.
H
H
H
174.
H
H
H
175.
H
H
H
176.
H
H
H
177.
H
H
H
178.
CD3
H
H
H
H
179.
H
CD3
H
H
H
180.
H
H
CD3
H
H
181.
H
H
H
CD3
H
182.
CD3
H
CD3
H
H
183.
CD3
H
H
CD3
H
184.
H
CD3
CD3
H
H
185.
H
CD3
H
CD3
H
186.
H
H
CD3
CD3
H
187.
CD3
CD3
CD3
H
H
188.
CD3
CD3
H
CD3
H
189.
CD3
H
CD3
CD3
H
190.
H
CD3
CD3
CD3
H
191.
CD3
CD3
CD3
CD3
H
192.
H
H
H
H
CD3
193.
CH3
H
H
H
CD3
194.
H
CH3
H
H
CD3
195.
H
H
CH3
H
CD3
196.
H
H
H
CH3
CD3
197.
CH3
H
CH3
H
CD3
198.
CH3
H
H
CH3
CD3
199.
H
CH3
CH3
H
CD3
200.
H
CH3
H
CH3
CD3
201.
H
H
CH3
CH3
CD3
202.
CH3
CH3
CH3
H
CD3
203.
CH3
CH3
H
CH3
CD3
204.
CH3
H
CH3
CH3
CD3
205.
H
CH3
CH3
CH3
CD3
206.
CH3
CH3
CH3
CH3
CD3
207.
H
H
H
CD3
208.
CH3
H
H
CD3
209.
H
CH3
H
CD3
210.
H
H
CH3
CD3
211.
CH3
CH3
H
CD3
212.
CH3
H
CH3
CD3
213.
H
CH3
CH3
CD3
214.
CH3
CH3
CH3
CD3
215.
H
H
H
CD3
216.
CH3
H
H
CD3
217.
H
CH3
H
CD3
218.
H
H
CH3
CD3
219.
CH3
CH3
H
CD3
220.
CH3
H
CH3
CD3
221.
H
CH3
CH3
CD3
222.
CH3
CH3
CH3
CD3
223.
H
H
H
CD3
224.
CH3
H
H
CD3
225.
H
CH3
H
CD3
226.
H
H
CH3
CD3
227.
CH3
CH3
H
CD3
228.
CH3
H
CH3
CD3
229.
H
CH3
CH3
CD3
230.
CH3
CH3
CH3
CD3
231.
H
H
H
CD3
232.
CH3
H
H
CD3
233.
H
CH3
H
CD3
234.
H
H
CH3
CD3
235.
CH3
CH3
H
CD3
236.
CH3
H
CH3
CD3
237.
H
CH3
CH3
CD3
238.
CH3
CH3
CH3
CD3
239.
H
H
H
CD3
240.
CH3
H
H
CD3
241.
H
CH3
H
CD3
242.
H
H
CH3
CD3
243.
CH3
CH3
H
CD3
244.
CH3
H
CH3
CD3
245.
H
CH3
CH3
CD3
246.
CH3
CH3
CH3
CD3
247.
H
H
H
CD3
248.
CH3
H
H
CD3
249.
H
CH3
H
CD3
250.
H
H
CH3
CD3
251.
CH3
CH3
H
CD3
252.
CH3
H
CH3
CD3
253.
H
CH3
CH3
CD3
254.
CH3
CH3
CH3
CD3
255.
H
H
H
CD3
256.
CH3
H
H
CD3
257.
H
CH3
H
CD3
258.
H
H
CH3
CD3
259.
CH3
CH3
H
CD3
260.
CH3
H
CH3
CD3
261.
H
CH3
CH3
CD3
262.
CH3
CH3
CH3
CD3
263.
H
H
H
CD3
264.
CH3
H
H
CD3
265.
H
CH3
H
CD3
266.
H
H
CH3
CD3
267.
CH3
CH3
H
CD3
268.
CH3
H
CH3
CD3
269.
H
CH3
CH3
CD3
270.
CH3
CH3
CH3
CD3
271.
H
H
H
CD3
272.
CH3
H
H
CD3
273.
H
CH3
H
CD3
274.
H
H
CH3
CD3
275.
CD3
CD3
CD3
CD3
CD3

### Claim 14 (depends on 1)

The compound of claim 1, wherein the compound has formula (LA)mPt(LC)2-m;
wherein LC is a bidentate ligand; and m is 1, or 2.

### Claim 15

An organic light-emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer, disposed between the anode and the cathode, comprising a compound comprising a ligand LA of Formula I:
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
wherein R1 represents from none to the maximum possible number of substitution;
wherein R2 represents from two to the maximum possible number of substitution;
wherein at least two adjacent R2s are joined to form ring C and have the following formula, wherein ring C is fused to ring B:
wherein the wave lines indicate bonds to ring B;
wherein ring D and ring E are each independently a 6-membered aromatic ring;
wherein ring D fuses to ring C, and ring E fuses to ring D;
wherein ring D and ring E can be further substituted by one or more substituents;
wherein X is selected from the group consisting of O, S, Se, and NR;
wherein R1, R2, and R are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;
wherein LA is coordinated to a metal M;
wherein LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein M is optionally coordinated to other ligands.

### Claim 16 (depends on 15)

The OLED of claim 15, wherein the organic layer is an emissive layer and the compound is an emissive dopant or a non-emissive dopant.

### Claim 17 (depends on 15)

The OLED of claim 15, wherein the organic layer further comprises a host, wherein host comprises at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiphene, dibenzofuran, dibenzoselenophene, aza-triphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.

### Claim 18 (depends on 15)

The OLED of claim 15, wherein the organic layer further comprises a host, wherein the host is selected from the group consisting of:
and combinations thereof.

### Claim 19

A consumer product comprising an organic light-emitting device (OLED) comprising:
an anode;
a cathode; and
an organic layer, disposed between the anode and the cathode, comprising a compound of Formula (I):
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
wherein R1 represents from none to the maximum possible number of substitution;
wherein R2 represents from two to the maximum possible number of substitution;
wherein at least two adjacent R2s are joined to form ring C and have the following formula, wherein ring C is fused to ring B:
wherein the wave lines indicate bonds to ring B;
wherein ring D and ring E are each independently a 6-membered aromatic ring;
wherein ring D fuses to ring C, and ring E fuses to ring D;
wherein ring D and ring E can be further substituted by one or more substituents;
wherein X is selected from the group consisting of O, S, Se, and NR;
wherein R1, R2, and R are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;
wherein LA is coordinated to a metal M;
wherein LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein M is optionally coordinated to other ligands.

### Claim 20 (depends on 19)

The consumer product of claim 19, wherein the consumer product is selected from the group consisting of a flat panel display, a computer monitor, a medical monitors television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video walls comprising multiple displays tiled together, a theater or stadium screen, and a sign.
